Nelia L.

Nelia L. is an accomplished Senior Clinical Trial Manager at Senti Biosciences, with extensive experience in planning and executing first-in-human Phase I clinical trials and developing innovative CAR NK cell therapies for hematological malignancies. Previously, Nelia held various roles at Evaxion Biotech A/S and Rigshospitalet, focusing on cancer immunology and the complement system. Academic credentials include a Master's degree in Immunology and Inflammation from Københavns Universitet and a Bachelor of Science in Neurobiology, Physiology, and Behavior from the University of California, Davis. Nelia's earlier experiences include veterinary internships at UC Davis Veterinary Medical Teaching Hospital and research roles at Berkeley Lab and UC Davis Center for Neuroscience.